Correspondence 0001193125-24-198971 from TuHURA Biosciences, Inc./NV (HURA)
TuHURA Biosciences, Inc./NV
Date: Aug. 12, 2024 · CIK: 0001498382 · Accession: 0001193125-24-198971
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279368
Letter
Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS
August 12, 2024
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, NE
Washington, D.C.
Kintara Therapeutics, Inc.
Registration Statement on Form S-4
File No. 333-279368
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the above-referenced registration statement to Tuesday, August 13, 2024, at 4:15 p.m., Eastern Time, or as soon thereafter as is practicable.
Thank you for your assistance. If you should have any questions, please contact Steven M. Skolnick of Lowenstein Sandler LLP, counsel to the Registrant, at (973) 597-2476.
Very truly yours,
KINTARA THERAPUETICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP August 12, 2024 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, NE Washington, D.C. 20549 Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS Kintara Therapeutics, Inc. Registration Statement on Form S-4 File No. 333-279368 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the above-referenced registration statement to Tuesday, August 13, 2024, at 4:15 p.m., Eastern Time, or as soon thereafter as is practicable. Thank you for your assistance. If you should have any questions, please contact Steven M. Skolnick of Lowenstein Sandler LLP, counsel to the Registrant, at (973) 597-2476. Very truly yours, KINTARA THERAPUETICS, INC. By: /s/ Robert E. Hoffman Name: Robert E. Hoffman Title: Chief Executive Officer